Evaluation of rapid screening methods for the detection of abnormal lipid states related to atherosclerosis.
D000362:Agar; D001161:Arteriosclerosis / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D001796:Blood Protein Disorders / Q000097:blood* / Q000175:diagnosis; D001798:Blood Proteins / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D002855:Chromatography, Thin Layer; D002914:Chylomicrons / Q000097:blood; D005069:Evaluation Studies as Topic; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008403:Mass Screening; D008722:Methods; D013053:Spectrophotometry; D014280:Triglycerides / Q000097:blood; D014461:Ultracentrifugation
D001798:Blood Proteins; D002914:Chylomicrons; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D000362:Agar; D002784:Cholesterol